羚锐制药

- 600285

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014  2013 
羚锐制药(600285) 利润表
单位:万元
报表日期2023-06-302023-03-312022-12-312022-09-302022-06-30
一、营业总收入170,066.2578,864.82300,186.22227,702.45150,267.88
营业收入170,066.2578,864.82300,186.22227,702.45150,267.88
二、营业总成本134,726.3762,276.47258,441.71190,846.69127,082.14
营业成本41,975.5118,506.5383,211.3860,931.6541,142.27
营业税金及附加2,364.661,091.984,091.623,117.161,978.91
销售费用79,146.1537,634.90144,350.07109,170.6172,230.34
管理费用8,428.373,504.4916,940.8412,492.938,522.47
财务费用-1,516.81-581.95-2,658.76-1,684.41-1,001.33
研发费用4,328.492,120.5212,506.566,818.744,209.49
资产减值损失----------
公允价值变动收益3.804.20592.60-0.91-0.25
投资收益664.87414.525,865.556,224.426,002.37
其中:对联营企业和合营企业的投资收益-7.953.864,334.965,032.335,068.39
汇兑收益----------
三、营业利润36,548.5217,063.0051,712.1545,676.0031,383.48
加:营业外收入27.564.3180.9865.6833.07
减:营业外支出130.7372.0289.6871.5663.95
其中:非流动资产处置损失----------
四、利润总额36,445.3416,995.2951,703.4545,670.1331,352.60
减:所得税费用4,742.612,577.265,170.335,128.604,290.34
五、净利润31,702.7314,418.0346,533.1240,541.5327,062.26
归属于母公司所有者的净利润31,698.1114,424.6446,533.0840,534.5327,051.78
少数股东损益4.62-6.610.047.0010.49
六、每股收益
基本每股收益(元/股)0.56300.26000.83600.73400.4900
稀释每股收益(元/股)0.55700.25400.81900.71000.4710
七、其他综合收益-15.5920.432,071.01-965.65-194.24
八、综合收益总额31,687.1414,438.4648,604.1339,575.8826,868.02
归属于母公司所有者的综合收益总额31,679.4614,443.8348,598.6339,567.2126,856.83
归属于少数股东的综合收益总额7.68-5.375.518.6711.19
下载全部历史数据到excel中 返回页顶